HDAC inhibitor SB939

DRUG2 trials

Sponsors

NCIC Clinical Trials Group

Conditions

Prostate CancerUnspecified Adult Solid Tumor, Protocol Specific

Phase 1

SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors

CompletedNCT00504296

NCIC Clinical Trials GroupUnspecified Adult Solid Tumor, Protocol Specific

Start: 2007-09-14End: 2011-06-21Updated: 2023-08-04

Phase 2

SB939 in Treating Patients With Recurrent or Metastatic Prostate Cancer

CompletedNCT01075308

NCIC Clinical Trials GroupProstate Cancer

Start: 2010-06-28End: 2015-02-13Updated: 2023-08-04